Kimberly Anderson - Publications
Affiliations: | University of California, Berkeley, Berkeley, CA, United States |
Year | Citation | Score | |||
---|---|---|---|---|---|
2018 | Counihan JL, Wiggenhorn AL, Anderson KE, Nomura DK. Chemoproteomics-Enabled Covalent Ligand Screening Reveals ALDH3A1 as a Lung Cancer Therapy Target. Acs Chemical Biology. PMID 30004670 DOI: 10.1021/Acschembio.8B00381 | 0.402 | |||
2017 | Lue HW, Podolak J, Kolahi K, Cheng L, Rao S, Garg D, Xue CH, Rantala JK, Tyner JW, Thornburg KL, Martinez-Acevedo A, Liu JJ, Amling CL, Truillet C, Louie SM, ... Anderson KE, et al. Metabolic reprogramming ensures cancer cell survival despite oncogenic signaling blockade. Genes & Development. PMID 29138276 DOI: 10.1101/Gad.305292.117 | 0.542 | |||
2017 | Anderson KE, To M, Olzmann JA, Nomura DK. Chemoproteomics-Enabled Covalent Ligand Screening Reveals a Thioredoxin-Caspase 3 Interaction Disruptor that Impairs Breast Cancer Pathogenicity. Acs Chemical Biology. PMID 28892616 DOI: 10.1021/Acschembio.7B00711 | 0.621 | |||
2008 | Ghosh G, Bachas LG, Anderson KW. Biosensor incorporating cell barrier architectures on ion selective electrodes for early screening of cancer. Analytical and Bioanalytical Chemistry. 391: 2783-91. PMID 18537028 DOI: 10.1007/S00216-008-2192-8 | 0.321 | |||
Show low-probability matches. |